October 12, 2017
Change in Nexstim Plc’s Management Team
Media
October 12, 2017
Targovax announces one-year survival rate and safety data in the modified cohort of the TG01 trial in resected pancreatic cancer
October 06, 2017
Phase 2 Clinical Trial Data for WTX101 Published in The Lancet Gastroenterology & Hepatology
October 06, 2017
Strongbridge Biopharma plc Announces Closing of Public Offering of Ordinary Shares
October 04, 2017
Strongbridge Biopharma plc Announces Pricing of Public Offering of Ordinary Shares
October 04, 2017
GenSight Biologics to Attend Chardan Gene Therapy Conference
October 03, 2017
Targovax granted US Patent for mutant-RAS neoantigen platform 2nd generation product TG02
October 03, 2017
Strongbridge Biopharma plc Announces Proposed Public Offering of Ordinary Shares
October 02, 2017
GenSight Biologics integrates the Enternext PEA-PME 150 index
October 02, 2017
Onxeo Introduces platON™, a Proprietary Chemistry Platform of Decoy Oligonucleotides
